Long-term Effects of COVID-19: a Comparative Cohort Study
NCT ID: NCT05002205
Last Updated: 2021-08-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
180 participants
OBSERVATIONAL
2021-08-31
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-Term Experience and Health Effects of COVID-19
NCT04477902
poSt Covid-19 Infection centraL sENsitisaTion
NCT04703452
Covid-19 Long-term Revalidation Follow-up
NCT04685629
poSt Covid-19 Infection centraL Sensitisation 2
NCT04701892
Virological and Immunological Monitoring in Patients (suspected Of/confirmed With) COVID-19
NCT04904692
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COVID-19
exposed cohort with a diagnosis of COVID-19 in the last 6 months
Questionnaires
Participants will be followed up by means of online surveys and 2 study visits.
spirometry
During two study visits, the lung function will be measured (FVC, FEV1)
ECG
During two study visits, the presence of arrhythmia will be explored.
1 minute sit to stand test
Physical endurance is tested during 2 study visits.
Vital parameters
blood pressure, pulse, weight
no history of COVID-19
non-exposed cohort without a diagnosis of COVID-19. Tested for COVID-19 because of symptoms at the same time (+/- 1 month) as the exposed cohort.
Questionnaires
Participants will be followed up by means of online surveys and 2 study visits.
spirometry
During two study visits, the lung function will be measured (FVC, FEV1)
ECG
During two study visits, the presence of arrhythmia will be explored.
1 minute sit to stand test
Physical endurance is tested during 2 study visits.
Vital parameters
blood pressure, pulse, weight
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaires
Participants will be followed up by means of online surveys and 2 study visits.
spirometry
During two study visits, the lung function will be measured (FVC, FEV1)
ECG
During two study visits, the presence of arrhythmia will be explored.
1 minute sit to stand test
Physical endurance is tested during 2 study visits.
Vital parameters
blood pressure, pulse, weight
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Aged 18 years or older;
2. Positive result on a rapid Ag test or PCR for SARS-CoV-2 for Covid-19 compatible symptoms a maximum of 6 months before inclusion;
3. Patient is community-dwelling;
4. Participant or their proxy is willing and able to give informed consent for participation in this study;
5. Participant is willing to comply with all study procedures.
Participants are sampled in the same practices as the exposed cohort and are eligible for inclusion in this study for the non-exposed without a diagnosis of COVID-19 in the last 6 months when they meet all of the following criteria:
1. Aged 18 years or older;
2. Tested because of suggestive symptoms with a rapid Ag test or PCR for SARS-CoV-2 at the same time (+/- 1 month) as the exposed cohort, of which the result was negative
3. Patient is community-dwelling;
4. Participant or their proxy is willing and able to give informed consent for participation in this study;
5. Participant is willing to comply with all study procedures.
Exclusion Criteria
1. Patients in palliative care;
2. Patients for whom there is already someone from the same household participating;
3. Judgement of the recruiting clinician deems participant ineligible.
Participants eligible for the cohort without COVID-19 must not meet any of the following criteria:
1. A positive test for a SARS-CoV-2 infection in the last 2 years;
2. Patients in palliative care;
3. Patients for whom there is already someone from the same household participating;
4. Judgement of the recruiting clinician deems participant ineligible.
Prior vaccination against Covid-19 is not an exclusion criterion.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ann Van den Bruel
Associate professor
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Ann Van den Bruel, Prof MD
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S65768
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.